Skip to main content

Education/ACR/EULAR

Download the latest RheumNow podcast. Available on Soundcloud and where you get you podcasts. https://t.co/uPNyVzFaZF https://t.co/gzIZpsinz9
Dr. John Cush @RheumNow( View Tweet )
Jun 21, 2021

Which patients with psoriasis are at risk to develop PsA?

The potential transition from psoriasis (PsO) to psoriatic arthritis (PsA) has not been a strong focus for several years but is gaining momentum.



Many patients do have psoriasis before onset of symptoms. This question can either be explored retrospectively using existing data or

Read Article
Should we treat to target ourselves? Dr. David Liew ( @drdavidliew ) shares learnings from #EULAR2021. https://t.co/divGxNku6a https://t.co/UBBH0QehY1
Dr. John Cush @RheumNow( View Tweet )
Jun 20, 2021

RheumNow Podcast - Speak Up! (6.18.2021)

Jun 18, 2021

Dr. Jack Cush talks on education, engagement and the challenge of speaking up, if not first!

Read Article

Do B-cell targeted therapies still have a place for the treatment of Sjogren’s?

B-cells play a major role in the pathogenesis of primary Sjogren’s syndrome (pSS) through antibody-dependent and antibody-independent functions, as well as evident by progression to B-cell malignancies/lymphoma. Hence, targeting B-cell is attractive. Despite efficacy of B-cell depleting therapy

Read Article
Our "Best of EULAR" podcast is available for download. https://t.co/dOqNum7nFr https://t.co/WW8wJUKOj7
Dr. John Cush @RheumNow( View Tweet )
Jun 17, 2021

EULAR 2021 – Day 4 Report

Jun 17, 2021

It's been nearly two weeks since EULAR 21 ended. There were several presentations on the last day; notably, the late breaking abstracts and others. Here are a few of my favorites from Day 4, the final day of the meeting.

Read Article

Artificial intelligence brings clarity to early bony changes in inflammatory arthritis

Jun 16, 2021

Subtle early bony changes in inflammatory arthritis can be hard even for experienced rheumatologists to interpret, even though they have traditionally been considered to become disease-defining as they progress. As computational techniques have become more sophisticated and more accessible,

Read Article

Psoriatic arthritis mortality & morbidities

Psoriatic arthritis (PsA) is a chronic condition with manifold clinical presentations. Health issues may be far beyond the classical associated conditions like uveitis, enthesitis etc. The current study of Tillett et al (OP0231) assessed comorbidities and patient characteristics comparing

Read Article
Miss something at #EULAR2021? Check out the Day 3 report. https://t.co/X7zxsKW8eL https://t.co/IDvukvfN9J
Dr. John Cush @RheumNow( View Tweet )
Jun 15, 2021
How has the pandemic impacted rheumatology training? Dr. Kathryn Dao ( @KDAO2011 ) and Dr. Young discuss. https://t.co/zYPd4hDzjV https://t.co/uuqDRXHWsN
Dr. John Cush @RheumNow( View Tweet )
Jun 15, 2021
Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting. Listen to the RheumNow podcast and catch up on #EULAR2021. https://t.co/qiSq8cVtuk https://t.co/FVy453hvVN
Dr. John Cush @RheumNow( View Tweet )
Jun 14, 2021

Current approach to lupus and pregnancy

Jun 14, 2021

All of us are extremely cautious with lupus patients when it comes to pregnancy. Presentation 6888 (Common issues in pregnancy management in lupus and anti-phospholipid syndrome by Dr. Rebecca Fischer-Betz) was an excellent overview of our current approach to lupus and pregnancy. 

Read Article
What is the impact of mental health and nephritis on SLE? Watch the video from Dr. Janet Pope ( @Janetbirdope ) as she reviews abstract POS0351, POS0681 and POS0304 presented at the virtual #EULAR2021 meeting. https://t.co/neJIdKkhJi https://t.co/YGXUHBsG3d
Dr. John Cush @RheumNow( View Tweet )
Jun 12, 2021

RheumNow Podcast - Best of EULAR 2021

Jun 11, 2021

Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting.

Read Article
WATCH: How does stress intersect with the onset of RA? Dr. David Liew ( @drdavidliew ) reviews abstract POS0310 presented at the virtual #EULAR2021 meeting. https://t.co/Oir9ZV3m7i https://t.co/Fs1O920S2L
Dr. John Cush @RheumNow( View Tweet )
Jun 11, 2021
WATCH: Have you heard about the advances in RA discussed at #EULAR2021? Our panel of doctors break down everything you need to know. https://t.co/C4FAQRFOhG https://t.co/tsQDW7LOFZ
Dr. John Cush @RheumNow( View Tweet )
Jun 10, 2021
Promising options to treat mucocutaneous disease in SLE #EULAR2021 https://t.co/JoChBNRfqu https://t.co/6jjhuEOQgO
Dr. John Cush @RheumNow( View Tweet )
Jun 09, 2021

RA ILD: Stepping out of the shadows

Jun 09, 2021

Despite being relatively common and frequently severe, RA-ILD has been a neglected area of research and indeed of clinical management in RA. In recent years we finally seem to have started making some progress in this area and this momentum has continued with a several interesting abstracts at

Read Article

EULAR 2021 Best Abstracts - Day 1

Jun 09, 2021

RheumNow faculty reporters scoured the Posters and Presentations from virtual EULAR 2021.  Several of these are novel enough to be worthy of your consideration.  Below is the list of the six most often retweeted abstracts from Day 1.

Read Article
Can the Focus Score predict Lymphoma in Sjogren’s syndrome? by Dr. Eric Dein ( @ejdein1 ) https://t.co/B5HN6ju3ru https://t.co/3MuXH66YqJ
Dr. John Cush @RheumNow( View Tweet )
Jun 09, 2021
Video: Did I Forget Something? Dr. Jonathan Kay ( @RheumKay ) Dr. Jonathan Kay examines abstracts OP0216 and OP0215 that were presented at the virtual #EULAR2021 meeting. https://t.co/Vaa570r7WE https://t.co/mNQJyOiNep
Dr. John Cush @RheumNow( View Tweet )
Jun 09, 2021

Lessons learned in SLE

An analysis of SLE samples from SLE 1760 patients with active disease from RCTs illustrated several known and some new targets for SLE treatment (POS0351). Markers of pathways

Read Article

Combination vs. Sequential Therapy for the Treatment of Lupus Nephritis

Jun 08, 2021

Combination disease modifying antirheumatic drug (DMARD) therapy may not be only for rheumatoid arthritis; combining disease modifying agents may be the path to better renal response. 

Read Article

Promising options to treat mucocutaneous disease in SLE

Cutaneous lupus erythematosus (CLE) consists of a wide range of dermatologic manifestations seen in people with or without systemic lupus erythematosus (SLE). CLE can be categorised into LE-specific lesions, i.e. acute CLE (ACLE), subacute CLE (SCLE) and chronic CLE (CCLE), and nonspecific LE

Read Article
×